Transdermal delivery systems in cosmetics

Alexander A, Dwivedi S, Ajazuddin, Giri TK, Saraf S, Saraf S, Tripathi DK. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release. 2012;164:26–40. Anderson RL, Cassidy JM. Variation in physical dimensions and chemical composition of human stratum corneum. J Invest Dermatol. 1973;61:30–2. Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res. 2011;28:978–85. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today. 2007;12:1061–7. Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm. 2008;364:227–36. Aungst BJ. Absorption enhancers: applications and advances. AAPS J. 2012;14:10–8. Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes--non-ionic surfactant vesicles. J Pharm Pharmacol. 1985;37:863–8. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–52. Banker GS. The theory and practice of industrial pharmacy. J Pharm Sci. 1970;59:1531. Barry BW. Dermatological formulations: percutaneous absorption. Drugs Pharm Sci. 1983;18:1–39 https://doi.org/10.1016/0306-3623(84)90021-1. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6:85–97. Barry BW. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release. 1991;15:237–48. Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2:23–33. Bhatia KS, Gao S, Singh J. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J Control Release. 1997;47:81–9. Boonme P. Applications of microemulsions in cosmetics. J Cosmet Dermatol. 2007;6:223–8. Bouwstra JA, Gooris GS, van der Spek JA, Bras W. Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol. 1991;97:1005–12. Brannon-Peppas L. Preparation and characterization of crosslinked hydrophilic networks. In: Studies in Polymer Science, vol. 8; 1990. p. 45–66. https://doi.org/10.1016/B978-0-444-88654-5.50008-X. Cansell MS, Moussaoui N, Mancini M. Prostaglandin E2 and interleukin-8 production in human epidermal keratinocytes exposed to marine lipid-based liposomes. Prostaglandin. 2007;343:277–80 https://doi.org/10.1016/j.ijpharm.2007.04.014. Carvalho ALM, Silva JA, AAM L, EDP A, Nunes RS, VHV S, LMC V, de Almeida Leite JR, Leal LB, de Santana DP. Third-generation transdermal delivery systems containing zidovudine: effect of the combination of different chemical enhancers and a microemulsion system. AAPS Pharm Sci Tech. 2018;19:3219–27. Cevc G, Blume G, Schätzlein A, Gebauer D, Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Delivery Rev. 1996;18:349–78. Cevc G, Schätzlein A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release. 1995;36:3–16. Chantasart D, Pongjanyakul T, Higuchi WI, Li SK. Effects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane. J Pharm Sci. 2009;98:3617–32. Chen Y, Quan P, Liu X, Wang M, Fang L. Novel chemical permeation enhancers for transdermal drug delivery. Asian J Pharm Sci. 2014;9:51–64. Chi SC, Park ES, Kim H. Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm. 1995;126:267–74. Chien YW, Xu HL, Chiang CC, Huang YC. Transdermal controlled administration of indomethacin. I. Enhancement of skin permeability. Pharm Res. 1988;5:103–6. Choi SG, Baek EJ, Davaa E, Nho YC, Lim YM, Park JS, et al. Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam. Int J Pharm. 2013;447:102–8. Danielsson I, Lindman B. The definition of microemulsion. Colloids Surf. 1981;3:391–2. Dastidar P. Supramolecular gelling agents: can they be designed? Chem Soc Rev. 2008;37:2699–715. Decome L, De Méo M, Geffard A, Doucet O, Duménil G, Botta A. Evaluation of photolyase (photosome) repair activity in human keratinocytes after a single dose of ultraviolet B irradiation using the comet assay. J Photochem Photobiol B. 2005;79:101–8. du Toit T, Malan MM, Lemmer HJR, Gouws C, Aucamp ME, Breytenbach WJ, Hamman JH. Combining chemical permeation enhancers for synergistic effects. Eur J Drug Metab Pharmacokinet. 2016;41:575–86. Elias PM. Lipids and the epidermal permeability barrier. Arch Dermatol Res. 1981;270:95–117. Elias PM, Grayson S, Lampe MA, Williams ML, Brown BE. The intercomeocyte space. In: Marks R, Plewig G, editors. Stratum Corneum. Berlin Heidelberg.: Springer-Verlag; 1983. p. 53–4. https://doi.org/10.1007/978-3-642-68682-5_7. El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm. 2000;198:179–89. El-Maghraby GM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm. 2004;276:143–61. Ferreira LAM, Seiller M, Grossiord JL, Marty JP, Wepierre J. Vehicle influence on in vitro release of glucose: w/o, w/o/w and o/w systems compared. J Controlled Release. 1995;33(3):349–56 https://doi.org/10.1016/0168-3659(94)00099-G. Flanagan J, Kortegaard K, Neil Pinder D, Rades T, Singh H. Solubilisation of soybean oil in microemulsions using various surfactants. Food Hydrcoll. 2006;20:253–60. Fox LT, Gerber M, Du Plessis JD, Hamman JH. Transdermal drug delivery enhancement by compounds of natural origin. Molecules. 2011;16:10507–40. Friberg SE, Solans C. Surfactant association structures and the stability of emulsions and foams. Langmuir. 1986;2:121–6. Friend D, Catz P, Heller J, Reid J, Baker R. Transdermal delivery of levonorgestrel I. Alkanols as permeation enhancers in vitro. J Control Release. 1988;7:243–50. Geusens B, Strobbe T, Bracke S, Dynoodt P, Sanders N, Van Gele M, Lambert J. Lipid-mediated gene delivery to the skin. Eur J Pharm Sci. 2011;43:199–211. Ghaffarian R, Muro S. Models and methods to evaluate transport of drug delivery systems across cellular barriers. J Vis Exp. 2013;80:e50638. Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release. 2004;99:113–25. Ghanem AH, Mahmoud H, Higuchi WI, Liu P, Good WR. The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: methods/validation of a novel approach. Int J Pharm. 1992;78:137–56. Gonnet M, Lethuaut L, Boury F. New trends in encapsulation of liposoluble vitamins. J Control Release. 2010;146:276–90. Gratieri T, Kalaria D, Kalia YN. Non-invasive iontophoretic delivery of peptides and proteins across the skin. Expert Opin Drug Deliv. 2011;8:645–63. Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–40. Handjani RM, Ribier A, Vanlerberghe G, Zabotto A, Griat J. Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions. Gen Pharmacol. 1989;20;(6):V https://doi.org/10.1016/0306-3623(89)90374-1. Holbrook KA, Odland GF. Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J Invest Dermatol. 1974;62:415–22. Hougeir FG, Kircik L. A review of delivery systems in cosmetics. Dermatol Ther. 2012;25:234–7. Hsieh DS. Drug permeation enhancement - theory and applications. Drug Dev Ind Pharm. 1994;20:1829. Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 2015;6:219. Hussan R. Nanoemulsion as a novel transdermal drug delivery system. Int J Pharm Sci Res. 2011;2:1938–46 https://doi.org/10.1016/j.molliq.2018.09.025. Imlmal E, Rekax C. Vehicle influence on in vitro release of glucose: w/o, w/o/w and o/w systems compared. J Control Release. 1995;33:349–56. Iwai H, Fukasawa J, Suzuki T. A liquid crystal application in skin care cosmetics. International Journal Cosmetic Sci. 1998;20:87–102. Jain AK, Thomas NS, Panchagnula R. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release. 2002;79:93–101. Jean-Louis S. Formulation concepts for emulsion maker. In: Marcel Dekker Nielloud F, Marti-Mestres G, editors. The Pharmaceutical emulsions and suspensions; 2000. p. 20–68. Kahlweit M, Busse G, Faulhaber B. Preparing nontoxic microemulsions. Langmuir. 1995;11:4185–7. Kalia YN, Guy RH. Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo. J Control Release. 1997;44:33–42. Kanikkannan N, Babu RJ. Structure-activity relationship of chemical penetration enhancers. In: Dragicevic N, Maibach HI, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement: modification of the stratum corneum. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 39–54. https://doi.org/10.1007/978-3-662-47039-8_4. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem. 2000;7(6):593–608 https://doi.org/10.2174/0929867003374840. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102:4688–93. Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol. 2004;22:192–7. Katz M, Poulsen BJ. Absorption of drugs through the skin. In: Concepts in biochem pharmacol. Berlin Heidelberg: Springer-Verlag; 1971;3(1). p. 103-104. https://doi.org/10.1007/978-3-642-65052-9_7. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM. Human stratum corneum lipids: characterization and regional variations. J Lipid Res. 1983;24:120–30. Lashmar UT, Hadgraft J, Thomas N. Topical application of penetration enhancers to the skin of nude mice—a histopatholgical study. J Pharm Pharmacol. 1989;41:188–22. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Delivery Rev. 2012;64(Suppl):175–93. Lupi FR, Gentile L, Gabriele D, Mazzulla S, Baldino N, de Cindio B. Olive oil and hyperthermal water bigels for cosmetic uses. J Colloid Interface Sci. 2015;459:70–8. Mathur V, Satrawala Y, Rajput M. Physical and chemical penetration enhancers in transdermal drug delivery system. Asian J Pharm. 2010;4:173. McClements DJ, Decker EA, Weiss J. Emulsion-based delivery systems for lipophilic bioactive components. J Food Sci. 2007;72:R109–24. Mckenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1962;86. McNaught AD, Wilkinson A. Volume of activation; 1997. p. 1598. https://doi.org/10.1351/goldbook.V06644. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and invitro experimental measurement. AIChE J. 1975;21:985–96. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm Res. 2000;17:1354–9. Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J, et al. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci. 2000;89:892–900. Montenegro L, Lai F, Offerta A, Sarpietro MG, Micicchè L, Maccioni AM, et al. From nanoemulsions to nanostructured lipid carriers: a relevant development in dermal delivery of drugs and cosmetics. J Drug Deliv Sci and Technol. 2016;32:100–12. Monti D, Saettone MF, Giannaccini B, Galli-Angeli D. Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J Control Release. 1995;33:71–7. Moore DJ, Rerek ME. Insights into the molecular organization of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. Acta Derm Venereol Suppl (Stockh). 2000;208:16–22. Morimoto K, Tojima H, Haruta T, Suzuki M, Kakemi M. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J Pharm Pharmacol. 1996;48:1133–7. Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF. Innovative strategies for enhancing topical and transdermal drug delivery. TODDJ. 2007;1:36–59. Mu L, Sprando RL. Application of nanotechnology in cosmetics. Pharm Res. 2010;27:1746–9. Narishetty ST, Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release. 2004;95:367–79. Noor MD, Zainab EJ, Mowafaq MG, Hiba Z. Studying the effect of different gelling agent on the preparation and characterization of metronidazole as topical emulgel. Asian J Pharm Clin Res. 2019;12(3):571–7 https://doi.org/10.22159/ajpcr.2019.v12i3.31504. Ogiso T, Tanino T. Transdermal delivery of drugs and enhancement of percutaneous absorption. Yakugaku Zasshi. 2000;120:328–38. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122:14–9. Otto A, du Plessis J, Wiechers JW. Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci. 2009;31:1–19. Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res. 2009;8:173–9. Patravale VB, Mandawgade SD. Novel cosmetic delivery systems: an application update. Int J Cosmet Sci. 2008;30:19–33. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50:27–46. Pfister WR, Hsieh DS. Permeation enhancers compatible with transdermal drug delivery systems. Part I: Selection and formulation considerations. Med Device Technol. 1990;1:48–55. Pham QD, Björklund S, Engblom J, Topgaard D, Sparr E. Chemical penetration enhancers in stratum corneum - relation between molecular effects and barrier function. J Control Release. 2016;232:175–87. Pillai O, Panchagnula R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J Controlled Release. 2003;89:127–40. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–8. Puri A, Murnane KS, Blough BE, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. Int J Pharm. 2017;528:452–62. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol. 1995;131:1134–8. Rehman K, Zulfakar MH. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm. 2014;40:433–40. Rodrigues Ueoka A, Pedriali MC. Development and stability evaluation of liquid crystal-based formulations containing glycolic plant extracts and nano-actives. Cosmetics. 2018;5:25. Roskos KV, Maibach HI, Guy RH. The effect of aging on percutaneous absorption in man. J Pharmacokinet Biopharm. 1989;17:617–30. Sapra B, Jain S, Tiwary AK. Percutaneous permeation enhancement by terpenes: mechanistic view. AAPS J. 2008;10:120–32. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48:79–88. Seto JE, Polat BE, Lopez RFV, Blankschtein D, Langer R. Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skin. J Control Release. 2010;145:26–32. Shakeel A, Lupi FR, Gabriele D, Baldino N, De Cindio B. Bigels: a unique class of materials for drug delivery applications. Soft Materials. 2018;16:77–93. Shen C, Shen B, Liu X, Yuan H. Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability. J Drug Deliv Sci Tech. 2018;43:1–11. Smith EW, Surber C, Tassopoulos T, Maibach HI. Topical dermatological vehicles: a holistic approach. In: Topical absorption of dermatological products: CRC Press; 2002. p. 472–9. https://doi.org/10.3109/9780203904015. Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci. 2012;4:2–9. Sommer E, Neubert RHH, Mentel M, Tuchscherer B, Mrestani Y, Wohlrab J. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III. Tetrapeptide GEKG. Eur J Pham Sci. 2018;124:137–44. Soni V, Chandel S, Jain P, Asati S; 2016. Role of liposomal drug-delivery system in cosmetics. In: Nanobiomaterials in galenic formulations and cosmetics. WA Press; 2016. p. 93-120. https://doi.org/10.1016/C2015-0-00402-6. Sonneville-Aubrun O, Simonnet JT, L’Alloret F. Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci. 2004;108–109:145–9. Stubenrauch C, Paeplow B, Findenegg GH. Microemulsions supported by octyl monoglucoside and geraniol. 1. The Role of the Alcohol in the Interfacial Layer. Langmuir. 1997;13:3652–8. Sugibayashi K, Nakayama S, Seki T, Hosoya KI, Morimoto Y. Mechanism of skin penetration-enhancing effect by laurocapram. J Pharm Sci. 1992;81:58–64. Swenson ES, Curatolo WJ. (C) Means to enhance penetration: (2) intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv Drug Delivery Rev. 1992;8(1):39–92. Tharwat T. Surfactants. In: Encyclopedia of colloid and interface science. Berlin, Heidelberg: Springer; 2013. https://doi.org/10.1007/978-3-642-20665-8. Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9:697–703. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403–18. Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006;19:106–21. Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995;58:1–55. Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release. 2004;97:55–66. Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 2010;1(3):274–82. https://doi.org/10.4103/0110-5558.72415. Vintiloiu A, Leroux JC. Organogels and their use in drug delivery - a review. J Control Release. 2008;125:179–92. Walker RB, Smith EW. The role of percutaneous penetration enhancers. Adv. Drug Delivery Rev. 1996;18:295–301. Wertz PW, Schwartzendruber DC, Madison KC, Downing DT. Composition and morphology of epidermal cyst lipids. J Invest Dermatol. 1989;35:1–17 https://doi.org/10.1111/1523-1747.ep12471781. Wichterle O, Lím D. Hydrophilic gels for biological use. Nature. 1960;185:117–8. Williams AC, Barry BW. Penetration enhancers. Advanced Drug Delivery Reviews. 2004;56(5):603–18. 10.1186/s41702-020-0058-7. Williams AC, Barry BW. Penetration enhancers. Adv. Drug Delivery Rev. 2012;64(Suppl):128–37. Wong O, Tsuzuki N, Nghiem B, Kuehnhoff J, Itoh T, Masaki K, et al. Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers: II. Evaluation study. Int J Pharm. 1989;52:191–202. Yang Y, Kalluri H, Banga AK. Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro. Pharmaceutics. 2011;3:474–84. Yarosh D, Klein J. The role of liposomal delivery in cutaneous DNA repair. Adv Drug Delivery Rev. 1996;18:325–33. Yarosh DB. Liposome dermatics. J Invest Dermatol. 1992;98:818.